Press release
Glioma Treatment Market Driven By The Surge In Demand For Personalized Medicine: A Significant Driver Propelling The Glioma Treatment Market In 2025
Glioma Treatment
What Is the Glioma Treatment Market Size and Projected Growth Rate?
The Glioma Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Glioma Treatment Market Size and Projected Growth Rate?
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10689
What Are the Major Segments in the Glioma Treatment Market?
The glioma treatment market covered in this report is segmented -
1) By Type: Low-Grade, High-Grade
2) By Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Other Treatments
5) By End-User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Low-Grade: Astrocytoma, Oligodendroglioma, Mixed Glioma
2) By High-Grade: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp
What Are The Driving Glioma Treatment Market Evolution?
The escalating need for personalized medicine is set to boost the expansion of the glioma treatment market in the future. Personalized medicine refers to a tailored healthcare approach that incorporates unique patient attributes such as genetic factors, environment, and lifestyle, to improve treatment efficiency and outcomes. The surging demand for this type of medicine is predicated upon several aspects, including genomics advancements, patient empowerment, and enhanced treatment efficacy. The discovery of biomarkers associated with gliomas assists in predicting treatment responses and outcomes, facilitating the creation of personalized treatment strategies adapted to each patient's unique traits. For example, in February 2024, records from the US-based non-profit organization, Personalized Medicine Coalition, showed that the FDA approved 16 new personalized therapies for patients suffering from rare diseases in 2023, a significant increase from just six in 2022. Therefore, this rising demand for personalized medicine is fueling the expansion of the glioma treatment market.
Which Firms Dominate The Glioma Treatment Market Segments?
Major companies operating in the glioma treatment market include Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.
What Trends Are Expected to Dominate the Glioma Treatment Market in the Next 5 Years?
The trend of product innovation is increasingly gaining traction in the glioma treatment industry. To maintain their competitive edge, major firms in the market are focusing on adopting novel, innovative products. For example, Servier Pharmaceuticals, a pharmaceutical corporation based in France, received approval from the FDA in June 2024 for VORANIGO (vorasidenib) tablets. This marked a substantial achievement as the initial targeted therapy for Grade 2 IDH-mutant glioma. Vorasidenib acts as a dual inhibitor that targets isocitrate dehydrogenase (IDH) mutations 1 and 2, commonly found in gliomas. These mutations result in the production of 2-hydroxyglutarate (2-HG), a growth and survival facilitating metabolite for tumors. The inhibition of these enzymes by vorasidenib, thereby reducing 2-HG levels, could potentially slow down tumor progression.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report
Which Is The Largest Region In The Glioma Treatment Market?
North America was the largest region in the glioma treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Glioma Treatment Market?
2. What is the CAGR expected in the Glioma Treatment Market?
3. What Are the Key Innovations Transforming the Glioma Treatment Industry?
4. Which Region Is Leading the Glioma Treatment Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glioma Treatment Market Driven By The Surge In Demand For Personalized Medicine: A Significant Driver Propelling The Glioma Treatment Market In 2025 here
News-ID: 3991739 • Views: …
More Releases from The Business Research Company
Kvass Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
The Kvass Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Kvass Market Size and Its Estimated Growth Rate?
The Kvass Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores…
The Symbiotic Surge Of The Oil And Gas Industry And Isolation Valve Market: Key …
The Isolation Valves Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Isolation Valves Market Size During the Forecast Period?
The Isolation Valves Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
Surging Demand For Halal Processed Food Drives Growth In The Halal Ingredients M …
The Halal Ingredients Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Halal Ingredients Market Size and Its Estimated Growth Rate?
The Halal Ingredients Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Strong Growth Ahead: Liquid Crystal Polymers Market Size To Grow At Arecord 9.6% …
The Liquid Crystal Polymers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Liquid Crystal Polymers Market Size Expected to Be by 2034?
The Liquid Crystal Polymers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from…
More Releases for Treatment
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of…
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking…
